Latest News and Press Releases
Want to stay updated on the latest news?
-
One Week Left to File for Lead Plaintiff Status in Canadian Solar Lawsuit Says Hagens Berman -- CSIQ
SAN FRANCISCO, July 26, 2010 (GLOBE NEWSWIRE) -- Hagens Berman announced today that CSIQ investors have about one week left to move for lead plaintiff in the class-action lawsuit against Canadian...
-
SAN FRANCISCO, July 20, 2010 (GLOBE NEWSWIRE) -- Hagens Berman announced today that CSIQ investors have about two weeks left to move for lead plaintiff in the class-action lawsuit against Canadian...
-
SAN FRANCISCO, July 7, 2010 (GLOBE NEWSWIRE) -- Hagens Berman announced today that it filed a new class-action lawsuit on behalf of shareholders against Canadian Solar, Inc. (Nasdaq:CSIQ) in...
-
SEATTLE, June 30, 2010 (GLOBE NEWSWIRE) -- Hagens Berman announced that an expanded class period for a class-action lawsuit filed against Canadian Solar, Inc allows more CSIQ purchasers to benefit...
-
SEATTLE, June 21, 2010 (GLOBE NEWSWIRE) -- Hagens Berman announced that an expanded class period for a class-action lawsuit filed against Canadian Solar, Inc. (Nasdaq:CSIQ), allows more CSIQ...
-
SEATTLE, June 10, 2010 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro today announced a class-action lawsuit has been filed against Canadian Solar, Inc. on behalf of investors who purchased the...
-
SEATTLE, June 2, 2010 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP (www.hbsslaw.com) today announced it is investigating Canadian Solar (Nasdaq:CSIQ) for potentially misrepresenting financial...
-
SEATTLE, April 13, 2010 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP is investigating Fuqi International Inc. (Nasdaq:FUQI) for potentially misrepresenting financial information to...
-
SEATTLE, March 3, 2010 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro is investigating high-profile Kirkland investment broker Rhonda Breard, a licensed broker for investment giant ING (NYSE:ING),...
-
SAN FRANCISCO, Jan. 18, 2010 (GLOBE NEWSWIRE) -- Hagens Berman is investigating claims whether pharmaceutical giant Johnson & Johnson (NYSE:JNJ) defrauded investors by not disclosing that some of...